Biogen Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biogen Inc with three other
pharmaceutical manufacturers in North America:
sales of $9.43 billion
of which 87%
Valeant Pharmaceuticals International Inc
(13.46 billion Canadian Dollars [US$10.21 billion]
of which 82%
was Developed Markets), and
of which 100%
Biogen Inc reported sales of $10.76 billion
December of 2015.
increase of 10.9%
versus 2014, when the company's sales were $9.70 billion.
Sales at Biogen Inc have increased during each of the previous five years
(and since 2010, sales have increased a total of 130%).